Home > Publications Database > SOD1-ALS mimicking an inflammatory neuropathy: a case report. > print |
001 | 280051 | ||
005 | 20250824001730.0 | ||
024 | 7 | _ | |a 10.1080/21678421.2025.2488296 |2 doi |
024 | 7 | _ | |a pmid:40219902 |2 pmid |
024 | 7 | _ | |a 2167-8421 |2 ISSN |
024 | 7 | _ | |a 2167-9223 |2 ISSN |
024 | 7 | _ | |a altmetric:176099356 |2 altmetric |
037 | _ | _ | |a DZNE-2025-00888 |
041 | _ | _ | |a English |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Lapp, Hanna Sophie |b 0 |
245 | _ | _ | |a SOD1-ALS mimicking an inflammatory neuropathy: a case report. |
260 | _ | _ | |a Abingdon |c 2025 |b Taylor Francis Group |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1753362911_6604 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a We present the case of a 36-year-old patient with a rapidly progressing SOD1-ALS, who was initially diagnosed as inflammatory acute motor axonal neuropathy due to contrast-enhancement of the lumbar spinal cord and a pure secondary motor neuron phenotype. Since the initiation of tofersen, disease progression and neurofilament levels impressively declined. |
536 | _ | _ | |a 353 - Clinical and Health Care Research (POF4-353) |0 G:(DE-HGF)POF4-353 |c POF4-353 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
650 | _ | 7 | |a ALS |2 Other |
650 | _ | 7 | |a Amyotrophic lateral sclerosis |2 Other |
650 | _ | 7 | |a MRI |2 Other |
650 | _ | 7 | |a SOD1 mutation |2 Other |
650 | _ | 7 | |a contrast enhancement |2 Other |
650 | _ | 7 | |a Superoxide Dismutase-1 |0 EC 1.15.1.1 |2 NLM Chemicals |
650 | _ | 7 | |a SOD1 protein, human |2 NLM Chemicals |
650 | _ | 2 | |a Humans |2 MeSH |
650 | _ | 2 | |a Adult |2 MeSH |
650 | _ | 2 | |a Amyotrophic Lateral Sclerosis: genetics |2 MeSH |
650 | _ | 2 | |a Amyotrophic Lateral Sclerosis: diagnosis |2 MeSH |
650 | _ | 2 | |a Diagnosis, Differential |2 MeSH |
650 | _ | 2 | |a Male |2 MeSH |
650 | _ | 2 | |a Superoxide Dismutase-1: genetics |2 MeSH |
650 | _ | 2 | |a Disease Progression |2 MeSH |
700 | 1 | _ | |a Günther, René |0 P:(DE-2719)2811849 |b 1 |e Last author |u dzne |
773 | _ | _ | |a 10.1080/21678421.2025.2488296 |g Vol. 26, no. 5-6, p. 591 - 594 |0 PERI:(DE-600)2705061-0 |n 5-6 |p 591 - 594 |t Amyotrophic lateral sclerosis & frontotemporal degeneration |v 26 |y 2025 |x 2167-8421 |
856 | 4 | _ | |y OpenAccess |u https://pub.dzne.de/record/280051/files/DZNE-2025-00888.pdf |
856 | 4 | _ | |y OpenAccess |x pdfa |u https://pub.dzne.de/record/280051/files/DZNE-2025-00888.pdf?subformat=pdfa |
909 | C | O | |o oai:pub.dzne.de:280051 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 1 |6 P:(DE-2719)2811849 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-353 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Clinical and Health Care Research |x 0 |
914 | 1 | _ | |y 2025 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2025-01-01 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2025-01-01 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2025-01-01 |
915 | _ | _ | |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0 |0 LIC:(DE-HGF)CCBYNCND4 |2 HGFVOC |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b AMYOTROPH LAT SCL FR : 2022 |d 2025-01-01 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2025-01-01 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2025-01-01 |
915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |d 2025-01-01 |
915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2025-01-01 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2025-01-01 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2025-01-01 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2025-01-01 |
920 | 1 | _ | |0 I:(DE-2719)1710012 |k AG Falkenburger |l Translational Parkinson Research |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a UNRESTRICTED |
980 | _ | _ | |a I:(DE-2719)1710012 |
980 | 1 | _ | |a FullTexts |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|